X4 Pharmaceuticals Secures $60M PIPE Financing

Deal News | Aug 13, 2025 | Paul Hastings

X4 Pharmaceuticals Secures $60M PIPE Financing

Paul Hastings LLP, a leading law firm, advised Stifel in its role as the sole placement agent for X4 Pharmaceuticals' (Nasdaq: XFOR) $60 million private placement in public equity (PIPE) financing. This significant transaction is anticipated to close around August 13, 2025, dependent upon customary closing conditions. The financing will allow X4 Pharmaceuticals to bolster its financial position, enabling continued operations and strategic initiatives. Spearheading the legal advice were Paul Hastings' Equity Capital Markets and Corporate Life Sciences chair Seo Salimi, along with of counsel Ryan Brewer. With a global presence across 17 core practices, Paul Hastings is renowned for its superior execution and client-focused approach in serving top-tier investment banks and corporations worldwide.

Sectors

  • Law
  • Pharmaceuticals
  • Finance

Geography

  • United States – The companies and the legal firm involved, such as Paul Hastings, Stifel, and X4 Pharmaceuticals, are based in the United States.

Industry

  • Law – The article discusses the role of Paul Hastings LLP, a law firm, in advising on a financial transaction.
  • Pharmaceuticals – X4 Pharmaceuticals, the target in the financing, operates within the pharmaceutical industry.
  • Finance – The transaction involves equity financing, placing it within the financial industry context.

Financials

  • $60 million – Amount raised by X4 Pharmaceuticals through PIPE financing.

Participants

NameRoleTypeDescription
Paul Hastings LLPLegal AdvisorCompanyLaw firm advising Stifel in X4 Pharmaceuticals' PIPE financing.
StifelSole Placement AgentCompanyServes as the sole placement agent in the financing deal for X4 Pharmaceuticals.
X4 PharmaceuticalsTarget CompanyCompanyEngaged in a $60 million PIPE financing with Stifel as the placement agent.
Seo SalimiEquity Capital Markets and Corporate Life Sciences chairPersonLed the Paul Hastings' team on the transaction.
Ryan BrewerOf CounselPersonPart of the Paul Hastings team advising on the transaction.